Advertisement

Topics

Synedgen Inc. Company Profile

18:40 EDT 24th June 2018 | BioPortfolio

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree and to reduce damage and inflammation due to chemical, radiological or physical damage using the science of glycomics - the study of complex sugar structure and function. Synedgen uses its Glycomics Technology Platform (GTP) to discover and develop ultra-purified glycopolymers that enhance and mimic the innate immune system by targeting the cell surface glycocalyx and mucosal surface.


News Articles [9 Associated News Articles listed on BioPortfolio]

Synedgen Receives FDA 510(k) Clearance for Catasyn™ Advanced Technology Wound Hydrogel

Synedgen, a company leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutics for infectious and inflammatory conditions, today announced...

Synedgen Announces Publication of Study Exploring the Role of Biological Ions in Controlling Mucosal Surfaces

-- New understanding of role of ions could impact treatment of infectious and inflammatory diseases -- Synedgen, a company leveraging its proprietary glycomics technology ...

Prisyna Appoints Leo Pranitis as General Manager

-- Experienced healthcare executive to build oral health franchise and expand Prisyna brand -- Prisyna, the oral care division of Synedgen, founded to optimize oral hea...

Faculty research describes how ions play key roles in controlling mucosal surfaces

(Keck Graduate Institute) Two recent papers from KGI Professor James Sterling and Shenda Baker, President and COO at Synedgen, describe how ions interact with the mucosal surface glycans to ensure hea...

Faculty research describes how ions play key roles in controlling mucosal surfaces

(Keck Graduate Institute) Two recent papers from KGI Professor James Sterling and Shenda Baker, President and COO at Synedgen, describe how ions interact with the mucosal surface glycans to ensure hea...

Synedgen Inc Medical Equipment Deals and Alliances Profile [Report Updated: 09022018] Prices from USD $250

SummarySynedgen Inc Synedgen is a biotechnology company that focuses on the discovery and development of polysaccharidebased drugs. The company's pipeline products include SYGN 113; SYGN 115; SYGN 146...

Synedgen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummarySynedgen Inc Synedgen is a biotechnology company that focuses on the discovery and development of polysaccharidebased drugs. The company's pipeline products include SYGN 113; SYGN 115; SYGN 146...

Synedgen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummarySynedgen Inc Synedgen is a biotechnology company that focuses on the discovery and development of polysaccharidebased drugs. The company's pipeline products include SYGN 113; SYGN 115; SYGN 146...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Synedgen Inc.

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree a...

Prisyna

Prisyna, the oral healthcare division of Synedgen, is developing and commercializing a new class of oral health care products based on glycomics, a revolutionary approach using na...

Synspira

Synspira is developing a new class of inhalable glycopolymer-based therapeutics that disrupt mucus accumulation and biofilm invasion, which are key drivers of pulmonary diseases i...

More Information about "Synedgen Inc." on BioPortfolio

We have published hundreds of Synedgen Inc. news stories on BioPortfolio along with dozens of Synedgen Inc. Clinical Trials and PubMed Articles about Synedgen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synedgen Inc. Companies in our database. You can also find out about relevant Synedgen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record